Medicine
Pedmark 12.5 g/100 mL injection
Pedmark 12.5 g/100 mL injection is a prescription medicine containing Sodium thiosulfate for intravenous use, marketed by Fennec Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions are permitted between 15°C…
Key facts
- Active ingredient (INN)
- Sodium thiosulfate
- Brand
- Pedmark
- Strength
- 12.5 g/100 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 100 mL
- Marketing authorisation holder
- Fennec Pharmaceuticals
- Manufacturer
- Fennec Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions are permitted between 15°C and 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AB06 Sodium thiosulfate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 October 2022
- Identifiers
- RxCUI 2618749, 2618755DailyMed set ID f98c7076-2a7b-4fd7-ab90-eed5e9137baeNDC 73077-010Application NDA212937
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 box, unit-dose / 100 mL in 1 vial, single-dose | 73077-010-01 | Fennec Pharmaceuticals | 3 October 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sodium thiosulfate
Clinical summary
Sodium thiosulfate is a prescription medicine indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening. It is available as injection for intravenous use. MedsAcross supplies Sodium thiosulfate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium thiosulfateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Sodium Thiosulfate prescribing information (Hope Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Pedmarqsi: European public assessment report (EPAR) · European Medicines Agency
Need Pedmark 12.5 g/100 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.